Stahlie EHA, Zijlker LP, Wouters MWJM, Schrage YM, et al. Real-world relapse-free survival data on adjuvant anti-PD-1 therapy for patients with newly diagnosed and recurrent stage III melanoma. Melanoma Res 2023 Nov 28. doi: 10.1097/CMR.0000000000000946.
PMID: 38016153